You are here

Article Text

Article menu

Download PDFPDF

Images in paediatrics
Pseudoporphyria secondary to non-steroidal anti-inflammatory drugs
Free
  1. P Bryant,
  2. P Lachman
  1. Northwick Park Hospital; penelope.bryantdoctors.org.uk

http://dx.doi.org/10.1136/adc.88.11.961

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A 3 year old girl with juvenile idiopathic arthritis (JIA) presented with recurrent blisters over the cheeks and nose which were initially treated as impetigo with flucloxacillin. Despite this, new blisters continued to appear which evolved into punched out lesions and healed with scars. She had been treated with naproxen 125 mg/day for six months. This is pseudoporphyria, an uncommon but well recognised side effect of non-steroidal anti-inflammatory drugs (NSAIDs), with cutaneous features in photosensitive areas indistinguishable from porphyria, but without the metabolic porphyrin abnormalities.1 The incidence of pseudoporphyria may be as high as 10% in children taking NSAIDs for JIA.1,2 Naproxen is the most common culprit, but the condition has been reported with other NSAIDs.3–7 Stopping the naproxen ceased the new blister formation and the ulcers healed, but faint scars remain. It is important for paediatricians to be aware of this disfiguring side effect of frequently prescribed drugs, as discontinuing the drug produces resolution.8


    Embedded Image

    Embedded Image

    REFERENCES

    1. ↵
      De Silva B, Banney L, Uttley W, et al. Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. Pediatr Dermatol2000;17:480–3.
      OpenUrlCrossRefPubMedWeb of Science
    2. ↵
      Wallace CA, Farrow D, Sherry DD. Increased risk of facial scars in children taking nonsteroidal antiinflammatory drugs. J Pediatr1994;125 (5 pt 1):819–22.
      OpenUrlPubMed
    3. ↵
      Creemers MC, Chang A, Franssen MJ, et al. Pseudoporphyria due to naproxen. A cluster of 3 cases. Scand J Rheumatol1995;24:185–7.
      OpenUrlPubMed
    4. Cheketts SR, Morrison KA, Baughman RD. Nonsteroidal anti-inflammatory-induced pseudoporphyria: is there an alternative drug? Cutis1999;63:223–5.
      OpenUrlPubMed
    5. Al-Khenaizan S, Schechter JF, Sasseville D. Pseudoporphyria induced by propionic acid derivatives. J Cutan Med Surg1999;3:162–6.
      OpenUrlPubMed
    6. Krischer J, Scolari F, Kondo-Oestreicher M, et al. Pseudoporphyria induced by nabumetone. J Am Acad Dermatol1999;40:492–3.
      OpenUrlPubMed
    7. ↵
      O’Hagan AH, Irvine AD, Allen GE, et al. Pseudoporphyria induced by mefenamic acid. Br J Dermatol1998;139:1131–2.
      OpenUrlPubMed
    8. ↵
      Anon. Drug-induced cutaneous photosensitivity: some drugs warrant routine precautions. Prescrire Int2000;9 (48):117–22.
      OpenUrlPubMed